27Jun 2024
Imfinzi Combo Shows Survival Boost in Bladder Cancer: NIAGARA Trial

Imfinzi Combo Shows Survival Boost in Bladder Cancer: NIAGARA Trial

AstraZeneca’s Imfinzi, combined with chemotherapy, excels in enhancing survival for muscle-invasive bladder cancer patients, marking a pivotal advance in perioperative care. The NIAGARA Phase III trial underscores Imfinzi's potential to redefine treatment standards by curbing recurrence post-cystectomy without surgical compromise.

  • #general surgery
  • #pharmacology
  • #general medicine
  • #psych
  • #rheumatology
  • #pathology
  • #radiology
  • #anaesthesia
  • #psychiatry
  • #fmt
  • #emergency medicine
  • #academics
  • #nursing
  • #pharmacy
  • #trichology
  • #andrology
  • #orthopaedics
  • #critical care
  • #dermatology
  • #dentistry
  • #oncology
  • #business
  • #gastroenterology
  • #nephrology
  • #diagnostics
  • #urology
  • #ophthalmology
  • #gynaecology - ivf
  • #pediatrics
  • #neurology
  • #ent
  • #pulmonology
  • #family health
  • #cardiology
  • #endo-diabetology

Like

Save

Share